Jude Clarke

Cancer Society of New Zealand

Papers

1

Total Citations

3

H-Index

1

About

Jude Clarke is a leading clinical researcher whose work focuses on improving outcomes for prostate cancer patients, particularly through predictive modeling of post-surgical quality of life. Their most-cited paper, "Predicting incontinence and erectile function after prostate cancer surgery: International validation of models" (2025, 3 citations), represents a critical advance in personalized medicine for oncology. By developing and internationally validating risk models that forecast two of the most feared side effects of radical prostatectomy—urinary incontinence and erectile dysfunction—Clarke has provided clinicians with evidence-based tools to better counsel patients before treatment. This work directly addresses a major gap in shared decision-making, helping men understand their individual risk profiles and set realistic expectations. While their citation count is still growing, the international scope of the validation study underscores its potential for broad clinical adoption. Clarke’s research bridges surgical oncology, patient-reported outcomes, and biostatistics, offering a patient-centered approach that prioritizes both cancer control and long-term quality of life. Their contributions are particularly valuable for urologists, radiation oncologists, and researchers developing risk-stratified care pathways in prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Predicting incontinence and erectile function after prostate cancer surgery: International validation of models
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Cancer Society of New Zealand

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago